Previous 10 | Next 10 |
This is not EF Hutton, but it could be more #powerful. A picture speaks a thousand words, they say, and the #priceaction of Perkinelmer (NYSE: PKI) tells an important story. The movement tells us where investors perceive value, or the lack of it, and if we pay attention we c...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Musk keeps roiling cryptoCryptocurrency is still under pressure this morning following tweets from Tesla (TSLA) CEO Elon Musk that rattled the market over ...
PerkinElmer (PKI) and Immunodiagnostic Systems Holdings ((IDS)) have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for ~$155M (£110M).The transaction has a total enterprise value of ~$124M (£88M) and is expected to close early...
PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approx...
PerkinElmer (PKI) has agreed to acquire private-held Nexcelom Bioscience for $260M in cash.Headquartered in Lawrence, Massachusetts Nexcelom is a developer and marketer of image cytometry products for cell analysis.The company with ~130 employees, has operations in the U.S., the UK, and China...
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing PerkinElmer, Inc . (NYSE: PKI) is pleased to announce it has entered into an agreement to acquir...
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 11, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer, announced that its T-SPOT ® . COVID test will be used for T cell testing in the COV-AD ( COV ID infection in patie...
Some people say that #timing does not matter, but it does. If you were to #buyandhold Perkinelmer (NYSE: PKI) at a high, see it fall, and not be able to buy more on the dip like the big boys can, that would be troubling. Over time, Stock Traders Daily has found a way...
Image source: The Motley Fool. PerkinElmer Inc (NYSE: PKI) Q1 2021 Earnings Call May 4, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: PerkinElmer Inc (PKI) Q1 2021 Earnings Call Transcript
PerkinElmer, Inc. (PKI) Q1 2021 Results Earnings Conference Call May 04, 2021, 5:00 pm ET Company Participants Bryan Kipp - Vice President of Investor Relations Prahlad Singh - President, Chief Executive Officer Jamey Mock - Senior Vice President, Chief Financial Officer Conference Call Parti...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...